⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

Official Title: Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

Study ID: NCT04732156

Conditions

Prostate Cancer

Study Description

Brief Summary: Multiparametric MRI of the prostate is recommended before each prostate biopsy. It identifies suspicious areas which will then be the subject of targeted biopsies. However, MRI suffers from low specificity and moderate inter-reader reproducibility, including with the use of the PI-RADS version 2.1 score. We are developing, within the framework of RHU PERFUSE, a computer-aided diagnosis system (CAD) for the detection of ISUP ≥2 cancers. This system has been trained on a database of patients who had prostate MRI and prostatectomy at the Hospices Civils de Lyon and performed well on a database of patients who had prostate MRI before biopsy at the Hopices civils de Lyon. However, one of the weaknesses of artificial intelligence systems is their low robustness when tested on MRI images from different manufacturers or institutions. The goal of the CHANGE study is to build a prospective multicenter cohort of patients who underwent prostate multiparametric MRI followed by systematic and targeted prostate biopsies. The cohort will be used for the final external validation of the CAD developed in PERFUSE.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

Department of radiology and urology, CHU Pellegrin, Bordeaux, , France

Department of urology and Radiology, CHU Grenoble Alpes, Grenoble, , France

Department of radiology and urology, CHU de Lille, Lille, , France

Department of radiology and urology, Hôpital Edouard Herriot, Lyon, , France

Department of radiology and urology, Hôpital Saint Joseph Saint Luc, Lyon, , France

Department of Radiology and Urology, Hopital Européen Marseille, Marseille, , France

Department of Radiology and Urology, Institut Paoli-Calmettes Marseille, Marseille, , France

Department of Urology, Clinique Beausoleil Montpellier, Montpellier, , France

Department of urology and Radiology, Montpellier, , France

Department Urology, Clinique urologique Nantes Atlantis, Nantes, , France

Department of radiology and urology, Hôpital la Pitié Salpêtrière, Paris, , France

Department of radiology, Hôpital Necker, Paris, , France

Department of urology and radiology, CHLS, Pierre-Bénite, , France

Department of Urology, Quint Fonsegrives, Quint Fonsegrives, , France

Department of urology, CHU de Saint-Étienne Hôpital Nord, Saint-Etienne, , France

Department of Radiology and Urology, Nouvel Hôpital Civil - CHU de Strasbourg, Strasbourg, , France

Department of Radiology adn Urology, Institut Universitaire du Cancer ,Toulouse, Toulouse, , France

Contact Details

Name: Olivier ROUVIERE, Pr

Affiliation: Service d'imagerie, pavillon B Hôpital Edouard Herriot

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: